"De locatie Erasmus MC-Daniel den Hoed bestaat niet meer. De patiëntenzorg is verhuisd naar Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam."

During the past decade, Erasmus Mc - Daniel Den Hoed Kliniek; Interne Oncologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Erasmus Mc - Daniel Den Hoed Kliniek; Interne Oncologie" are "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Carcinoma, Transitional Cell" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Erasmus Mc - Daniel Den Hoed Kliniek; Interne Oncologie" in a lesser frequency.

Most popular intervention types in "Erasmus Mc - Daniel Den Hoed Kliniek; Interne Oncologie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Cobimetinib" (2 trials), "Atezolizumab Placebo" (1 trials), "Pembrolizumab" (1 trials) and "Vemurafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Erasmus Mc - Daniel Den Hoed Kliniek; Interne Oncologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Erasmus Mc - Daniel Den Hoed Kliniek; Interne Oncologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Erasmus Mc - Daniel Den Hoed Kliniek; Interne Oncologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Erasmus Mc - Daniel Den Hoed Kliniek; Interne Oncologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".